AI Cancer Detection Startup C2i Genomics Partners with Israel's Top Hospital

站长之家

Published inAI News · 1 min read · Aug 21, 2023

Translated data: C2i Genomics has partnered with Tel Aviv's Sourasky Medical Center to utilize cloud-based AI solutions for early cancer detection. C2i Genomics specializes in whole genome minimal residual disease (MRD) detection, and this collaboration will drive research and clinical trials within the hospital, as well as facilitate drug development for pharmaceutical companies.

AI "Super Assistant" Liberates Medical Staff: Pharos' Intelligent Quality Reporting Secures $5 Million Funding

Healthcare startup Pharos has recently launched an innovative AI solution aimed at streamlining the cumbersome process of submitting quality reports to external clinical registries by hospitals. The company has just completed a $5 million seed funding round led by Felicis, with participation from General Catalyst, Moxxie, and Y Combinator. In the current healthcare system, submitting quality reports to institutions such as the Centers for Medicare and Medicaid Services (CMS) is an extremely time-consuming task.

Gartner Predicts: By 2027, 40% of Generative AI Solutions Will Achieve Multimodal Integration

At a recent Gartner IT symposium, analysts predicted that by 2027, 40% of generative artificial intelligence (GenAI) solutions will achieve multimodal integration, significantly up from 1% in 2023. The integration of multimodal GenAI can capture relationships between different data streams and expand benefits across various data and applications, supporting human multitasking in different environments. Gartner's report indicates that multimodal GenAI and open-source large language models will have a profound impact, benefiting enterprises in the next five years.

Galileo Launches New Tool for Enhanced Retrieval Generation to Assist Enterprises in Developing Reliable AI Solutions

Galileo has recently launched a new tool aimed at helping enterprises develop trustworthy artificial intelligence solutions. The new tool, named Retrieval-Enhanced Generation and Agent Analysis Solution, tackles complex RAG systems. The tool incorporates advanced insights and metrics, providing visibility into every stage of the RAG workflow, enabling rapid assessment and error detection. Galileo's tool transforms the AI development process, making AI applications more efficient and reliable, aligning with the future commercialization trends of AI.

Researchers Launch AI Detection Study for Aggressive Prostate Cancer

Researchers at the Jonsson Comprehensive Cancer Center at UCLA have received a five-year, $5 million grant to conduct artificial intelligence detection research for aggressive prostate cancer. Funded by the National Cancer Institute, the aim is to discover new cancer biomarkers and develop AI technologies for the detection and prediction of aggressive prostate cancer. Despite some progress in the diagnosis and treatment of prostate cancer, the disease remains a widespread issue in men's health.